|
Re: BETonMACE top line data
|
3
|
Resverlogix Corp.
|
Jan 16, 2018 12:00PM
|
|
Re: Barron's rating; albeit a single analyst:
|
5
|
Resverlogix Corp.
|
Dec 07, 2022 09:39AM
|
|
Re: Bankruptcy?
|
9
|
Resverlogix Corp.
|
Dec 19, 2023 09:24AM
|
|
Re: Bankruptcy?
|
3
|
Resverlogix Corp.
|
Dec 19, 2023 02:13PM
|
|
Re: Bankruptcy?
|
3
|
Resverlogix Corp.
|
Dec 20, 2023 12:37PM
|
|
Re: Apparently Don spoke other day, but not at ESC
|
6
|
Resverlogix Corp.
|
Aug 31, 2021 01:41AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 03:26PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
6
|
Resverlogix Corp.
|
Apr 21, 2021 10:20AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
9
|
Resverlogix Corp.
|
Mar 18, 2021 07:05PM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
5
|
Resverlogix Corp.
|
Mar 19, 2021 12:32AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
7
|
Resverlogix Corp.
|
Aug 19, 2024 07:51PM
|
|
Re: Another quarter and not a peep
|
6
|
Resverlogix Corp.
|
Jan 04, 2023 12:35AM
|
|
Re: Another quarter and not a peep
|
9
|
Resverlogix Corp.
|
Jan 04, 2023 11:03PM
|
|
Re: Another possibility...more from RVX Financials
|
2
|
Zenith Epigenetics
|
Dec 10, 2015 04:26PM
|
|
Re: Annual Financial Reporting
|
5
|
Zenith Epigenetics
|
Mar 22, 2024 03:15PM
|
|
Re: American Society of Nephrology Kidney Week
|
4
|
Resverlogix Corp.
|
Nov 04, 2017 02:42PM
|
|
Re: American Society of Nephrology Kidney Week
|
2
|
Resverlogix Corp.
|
Nov 04, 2017 02:56PM
|
|
Re: American Society of Nephrology Kidney Week
|
|
Resverlogix Corp.
|
Nov 04, 2017 03:56PM
|
|
Re: Alpine Immune buyout by Vertex
|
8
|
Zenith Epigenetics
|
Apr 11, 2024 11:23AM
|
|
Re: AGM Comments
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 04:31PM
|
